Cowen & Co. analyst Ritu Baral downgrades Aptinyx (NASDAQ:APTX) from Outperform to Market Perform.
Insiders Buying Pfizer And 3 Other Stocks
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.
Cowen & Co. Downgrades Aptinyx to Market Perform
Cowen & Co. analyst Ritu Baral downgrades Aptinyx (NASDAQ:APTX) from Outperform to Market Perform.
Related Posts
AppLovin Stock Jumps On Strong Q1 Earnings: The Details
AppLovin shares are trading higher in Wednesday's after-hours session after the company reported better-than-expected financial results for the first quarter.
C3.ai Shares Are Surging: What’s Going On?
C3.Ai Inc (NYSE: AI) shares are rallying Tuesday. The stock appears to be moving in anticipation of the company's quarterly results, which are due after the close Wednesday.
The CASE Groundbreaker Roadshow Takes A Second Tour through The U.S. To Celebrate The Launch of the Minotaur DL550 Compact Dozer Loader
New tour kicks off January 17, 2023 in St. Louis and travels all throughout the midwestern, western, southern and mid-Atlantic U.S. through March.
RACINE, Wis., Jan. 12, 2023 /PRNewswire/